Its activity is mainly dependent on the phosphorylation of AP-1 family members, which was confirmed here in RCC cells by repression of AP-1 activity in the presence of JNK inhibitor (Oh et al., 2017). Here, MAPK8 is linked to renal cell carcinoma.